Bulletin
Investor Alert

Caribou Biosciences Inc.

NAS: CRBU

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jun 9, 2023, 7:59 p.m.

/zigman2/quotes/228313444/composite

$

4.26

Change

-0.03 -0.70%

Volume

Volume 11,902

Quotes are delayed by 20 min

/zigman2/quotes/228313444/composite

Previous close

$ 4.47

$ 4.29

Change

-0.18 -4.03%

Day low

Day high

$4.27

$4.56

Open

52 week low

52 week high

$4.05

$13.19

Open

Insider Actions for Caribou Biosciences Inc.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
03/20/2023 Rachel E. Haurwitz
President and CEO; Director
10,000   Derivative/Non-derivative trans. at $2.96 per share. 29,600
01/19/2023 Syed Rizvi
Chief Medical Officer
5,627   Disposition at $6.31 per share. 35,506
12/02/2022 Steven B. Kanner
Chief Scientific Officer
21,401   Derivative/Non-derivative trans. at $2.69 per share. 57,568
10/06/2022 Ryan Fischesser
VP of Finance and Controller
2,839   Derivative/Non-derivative trans. at $4.11 per share. 11,668
10/06/2022 Ryan Fischesser
VP of Finance and Controller
2,839   Derivative/Non-derivative trans. at $2.69 per share. 7,636
10/06/2022 Ryan Fischesser
VP of Finance and Controller
10,000   Disposition at $10.8 per share. 108,000
09/15/2022 Barbara G. McClung
Chief Legal Officer
27,518   Derivative/Non-derivative trans. at $2.69 per share. 74,023
09/15/2022 Barbara G. McClung
Chief Legal Officer
77   Derivative/Non-derivative trans. at $2.69 per share. 207
08/25/2022 Steven B. Kanner
Chief Scientific Officer
43,248   Disposition at $11.22 per share. 485,242
08/25/2022 Steven B. Kanner
Chief Scientific Officer
43,248   Derivative/Non-derivative trans. at $2.69 per share. 116,337
08/22/2022 Ryan Fischesser
VP of Finance and Controller
4,848   Award at $0 per share. 0
05/13/2022 Steven B. Kanner
Chief Scientific Officer
6,114   Derivative/Non-derivative trans. at $2.69 per share. 16,446
05/13/2022 Steven B. Kanner
Chief Scientific Officer
68,306   Derivative/Non-derivative trans. at $1.81 per share. 123,633
05/09/2022 Rachel E. Haurwitz
President and CEO; Director
10,000   Derivative/Non-derivative trans. at $2.96 per share. 29,600
05/05/2022 Ryan Fischesser
VP of Finance and Controller
1,138   Derivative/Non-derivative trans. at $4.11 per share. 4,677
05/05/2022 Ryan Fischesser
VP of Finance and Controller
1,136   Derivative/Non-derivative trans. at $2.69 per share. 3,055

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
1 Purchases
0 Sales
10,000
0
Last 6 months
1 Purchases
1 Sales
10,000
5,627
Last 12 months
8 Purchases
3 Sales
112,770
58,875

Officers and Executives

Dr. Rachel E. Haurwitz
President, Chief Executive Officer & Director
Mr. Jason V. O’Byrne
Chief Financial & Accounting Officer
Dr. Steven B. Kanner
Chief Scientific Officer
Dr. Syed Rizvi
Chief Medical Officer
Ms. Ruhi Khan
Chief Business Officer
Mr. Ryan Fischesser
Vice President-Finance & Controller
Ms. Cindy Hayashi
Vice President-Human Resources
Ms. Barbara G. McClung
Secretary & Chief Legal Officer
Ms. Elaine Alambra
VP-Regulatory Affairs & Quality Assurance
Dr. Scott N. Braunstein
Independent Director
Mr. Andrew L. Guggenhime
Independent Director
Dr. Nancy C. Whiting
Independent Director
Ms. Ran Zheng
Independent Director
Dr. Dara Richardson-Heron
Independent Director
Mr. David L. Johnson
Independent Director
Dr. Natalie R. Sacks
Independent Director
Link to MarketWatch's Slice.